{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:21:34Z","timestamp":1753888894504},"reference-count":90,"publisher":"Oxford University Press (OUP)","issue":"1063","license":[{"start":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T00:00:00Z","timestamp":1397520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides are a heterogeneous group of diseases corresponding to necrotising inflammation of small vessels with a wide range of clinical presentations. At least two of the diseases are believed to exhibit a common ground of pathophysiological mechanisms. These are granulomatosis with polyangiitis (GPA, formerly known as Wegener\u2019s granulomatosis) and microscopic polyangiitis (MPA). ANCA directed against proteinase 3 (PR3) are preferentially associated with GPA, and anti-myeloperoxidase (MPO) ANCA are associated mainly with MPA and eosinophilic GPA (formerly known as Churg-Strauss syndrome). Anti-MPO and anti-PR3 antibodies can activate neutrophils in vitro. In vivo data are available for humans and mice on the pathogenicity of anti-MPO but it is more controversial for PR3-ANCA. A recent genome-wide association study of patients with ANCA-associated vasculitides confirmed the genetic contribution to the pathogenesis of these conditions, with significant association of PR3-ANCA and human leukocyte antigen-DP and the genes encoding \u03b11-antitrypsin and PR3. MPO-ANCA were significantly associated with human leukocyte antigen-DQ. Thus, recent results from epidemiological studies, genome-wide association study and therapeutic trials have suggested that these entities are, in fact, distinct. We have summarised these results and discuss the idea that these two entities should be studied separately as the nature of the two auto-antigens suggests at a molecular level despite shared ANCA involvement.<\/jats:p>","DOI":"10.1136\/postgradmedj-2013-203255rep","type":"journal-article","created":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T08:48:39Z","timestamp":1397551719000},"page":"290-296","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?"],"prefix":"10.1093","volume":"90","author":[{"given":"Arnaud","family":"Millet","sequence":"first","affiliation":[{"name":"INSERM U1016, Institut Cochin , Paris , France"},{"name":"CNRS UMR 8104 , Paris , France"},{"name":"Universit\u00e9 Paris-Descartes , Paris , France"},{"name":"Laboratoire d'Excellence INFLAMEX Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Pederzoli-Ribeil","sequence":"additional","affiliation":[{"name":"INSERM U1016, Institut Cochin , Paris , France"},{"name":"CNRS UMR 8104 , Paris , France"},{"name":"Universit\u00e9 Paris-Descartes , Paris , France"},{"name":"Laboratoire d'Excellence INFLAMEX Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[{"name":"H\u00f4pital Cochin, Assistance publique-H\u00f4pitaux de Paris, service de m\u00e9decine interne et centre de r\u00e9f\u00e9rence pour les vascularites n\u00e9crosantes et la scl\u00e9rodermie syst\u00e9mique , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Witko-Sarsat","sequence":"additional","affiliation":[{"name":"INSERM U1016, Institut Cochin , Paris , France"},{"name":"CNRS UMR 8104 , Paris , France"},{"name":"Universit\u00e9 Paris-Descartes , Paris , France"},{"name":"Laboratoire d'Excellence INFLAMEX Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Mouthon","sequence":"additional","affiliation":[{"name":"INSERM U1016, Institut Cochin , Paris , France"},{"name":"CNRS UMR 8104 , Paris , France"},{"name":"Universit\u00e9 Paris-Descartes , Paris , France"},{"name":"Laboratoire d'Excellence INFLAMEX Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,4,15]]},"reference":[{"key":"2023041905563273800_R1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.rdc.2010.04.002","article-title":"Epidemiology of ANCA-associated vasculitis","volume":"36","author":"Ntatsaki","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"2023041905563273800_R3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/art.11115","article-title":"The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions","volume":"49","author":"Gonzalez-Gay","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1189\/jlb.69.2.177","article-title":"Proteinase 3, Wegener\u2019s autoantigen: from gene to antigen","volume":"69","author":"van der Geld","year":"2001","journal-title":"J Leukoc Biol"},{"key":"2023041905563273800_R5","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1089\/ars.2009.2538","article-title":"Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease","volume":"11","author":"van der Veen","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"2023041905563273800_R6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-pathol-011811-132453","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis","volume":"8","author":"Jennette","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"2023041905563273800_R7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrrheum.2010.158","article-title":"ANCA-associated vasculitides\u2013advances in pathogenesis and treatment","volume":"6","author":"Chen","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2023041905563273800_R8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BOR.0b013e32834bde57","article-title":"Pathogenesis of ANCA-associated vasculitis: recent insights from animal models","volume":"24","author":"van Timmeren","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"2023041905563273800_R9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrrheum.2011.218","article-title":"Vasculitis in 2011: the renaissance of granulomatous inflammation in AAV","volume":"8","author":"Gadola","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"2023041905563273800_R10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2010.472","article-title":"New pathophysiological insights and treatment of ANCA-associated vasculitis","volume":"79","author":"Wilde","year":"2011","journal-title":"Kidney Int"},{"key":"2023041905563273800_R11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/rheumatology\/ker454","article-title":"The contrasting epidemiology of granulomatosis with polyangiitis (Wegener\u2019s) and microscopic polyangiitis","volume":"51","author":"Watts","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2023041905563273800_R12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2928","article-title":"The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis","volume":"12","author":"Willcocks","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2023041905563273800_R13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"2023041905563273800_R14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"2023041905563273800_R15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/40.2.178","article-title":"Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA","volume":"40","author":"Schonermarck","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"2023041905563273800_R16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2215\/CJN.03550807","article-title":"Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known","volume":"3","author":"de Lind van Wijngaarden","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023041905563273800_R17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"2023041905563273800_R18","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2012.05.058","article-title":"Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome","volume":"131","author":"Healy","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"2023041905563273800_R20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R21","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","article-title":"Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K","volume":"50","author":"Fujimoto","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2023041905563273800_R22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2010101058","article-title":"DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans","volume":"22","author":"Cao","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2023041905563273800_R23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ard.60.2.170","article-title":"Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2023041905563273800_R24","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/ard.60.12.1156a","article-title":"Epidemiology of vasculitis in Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2023041905563273800_R25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/art.20927","article-title":"Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term followup study","volume":"53","author":"Slot","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R26","doi-asserted-by":"crossref","first-page":"A293","DOI":"10.1016\/j.autrev.2009.10.008","article-title":"The environment, geoepidemiology and ANCA-associated vasculitides","volume":"9","author":"Chen","year":"2010","journal-title":"Autoimmun Rev"},{"key":"2023041905563273800_R27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"2023041905563273800_R28","first-page":"51","article-title":"Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps","volume":"28","author":"Laudien","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2023041905563273800_R29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/art.23157","article-title":"Risks and relative risks of Wegener\u2019s granulomatosis among close relatives of patients with the disease","volume":"58","author":"Knight","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R30","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.27742","article-title":"Alpha-antitrypsin deficiency-related alleles Z and S and the risk of Wegener\u2019s granulomatosis","volume":"62","author":"Mahr","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R31","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1046\/j.1523-1755.2000.00430.x","article-title":"Proteinase 3 gene polymorphisms and Wegener\u2019s granulomatosis","volume":"58","author":"Gencik","year":"2000","journal-title":"Kidney Int"},{"key":"2023041905563273800_R32","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","article-title":"Small-vessel vasculitis","volume":"337","author":"Jennette","year":"1997","journal-title":"N Engl J Med"},{"key":"2023041905563273800_R33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3899\/jrheum.100518","article-title":"Wegener\u2019s granulomatosis strictly and persistently localized to one organ is rare: assessment of 16 patients from the French Vasculitis Study Group database","volume":"38","author":"Pagnoux","year":"2011","journal-title":"J Rheumatol"},{"key":"2023041905563273800_R34","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener\u2019s granulomatosis: baseline data on patients in the Wegener\u2019s granulomatosis etanercept trial","volume":"48","author":"Stone","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R35","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1046\/j.1523-1755.2000.00080.x","article-title":"Antiproteinase 3- and antimyeloperoxidase-associated vasculitis","volume":"57","author":"Franssen","year":"2000","journal-title":"Kidney Int"},{"key":"2023041905563273800_R36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.2009.122952","article-title":"Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index","volume":"70","author":"Suppiah","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2023041905563273800_R37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.33361","article-title":"Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Walsh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R38","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/art.34562","article-title":"Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis","volume":"64","author":"Lionaki","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"2023041905563273800_R40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2249.2011.04364.x","article-title":"Cyclophosphamide as induction therapy for Wegener\u2019s granulomatosis and microscopic polyangiitis","volume":"164","author":"Langford","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"2023041905563273800_R41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"2023041905563273800_R42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl 10","key":"2023041905563273800_R43","first-page":"S660","article-title":"for the RAVE-Itn Research Group. The efficacy of rituximab vs cyclophosphamide for treatment of renal disease in ANCA-associated vasculitis: the RAVE Trial [abstract]","volume":"64","author":"Geetha","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"Suppl 10","key":"2023041905563273800_R44","first-page":"S706","article-title":"Rituximab versus azathioprine for maintenance in Antineutrophil Cytoplasmic Antibodies (ANCA)-associated vasculitis","volume":"64","author":"Guillevin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R45","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1002\/art.34583","article-title":"Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Smith","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R46","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener\u2019s): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","article-title":"Rituximab for refractory granulomatosis with polyangiitis (Wegener\u2019s granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations","volume":"71","author":"Holle","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2023041905563273800_R48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/ar3797","article-title":"Progress in treatment of ANCA-associated vasculitis","volume":"14","author":"Smith","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2023041905563273800_R49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1155\/S0962935194000360","article-title":"Neutrophil-derived oxidants and proteinases as immunomodulatory mediators in inflammation","volume":"3","author":"Witko-Sarsat","year":"1994","journal-title":"Mediators Inflamm"},{"key":"2023041905563273800_R50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002281-200401000-00004","article-title":"Clinical applications of antineutrophil cytoplasmic antibody testing","volume":"16","author":"Schmitt","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"2023041905563273800_R51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.ajkd.2005.09.022","article-title":"Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: systematic review","volume":"47","author":"Birck","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2023041905563273800_R52","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann Intern Med"},{"key":"2023041905563273800_R53","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/rheumatology\/kei272","article-title":"Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment","volume":"45","author":"Sanders","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2023041905563273800_R54","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/ard.2008.094714","article-title":"Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides","volume":"68","author":"Terrier","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2023041905563273800_R55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/rheumatology\/ker280","article-title":"Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis\u2014a meta-analysis","volume":"51","author":"Tomasson","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2023041905563273800_R56","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","article-title":"Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis","volume":"14","author":"Kain","year":"2008","journal-title":"Nat Med"},{"key":"2023041905563273800_R57","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2011090920","article-title":"High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"23","author":"Kain","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2023041905563273800_R58","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2011030273","article-title":"Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis","volume":"23","author":"Roth","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2023041905563273800_R59","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023041905563273800_R60","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","article-title":"Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa","volume":"153","author":"Porges","year":"1994","journal-title":"J Immunol"},{"key":"2023041905563273800_R61","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.4049\/jimmunol.161.12.6909","article-title":"Antineutrophil cytoplasmic antibodies preferentially engage Fc gammaRIIIb on human neutrophils","volume":"161","author":"Kocher","year":"1998","journal-title":"J Immunol"},{"key":"2023041905563273800_R62","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1046\/j.1365-2249.2003.02280.x","article-title":"Involvement of Fcgamma receptors and beta2 integrins in neutrophil activation by anti-proteinase-3 or anti-myeloperoxidase antibodies","volume":"134","author":"Reumaux","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"2023041905563273800_R63","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1189\/jlb.1102567","article-title":"Expression of myeloperoxidase (MPO) by neutrophils is necessary for their activation by anti-neutrophil cytoplasm autoantibodies (ANCA) against MPO","volume":"73","author":"Reumaux","year":"2003","journal-title":"J Leukoc Biol"},{"key":"2023041905563273800_R64","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1081-1206(10)61400-7","article-title":"Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement","volume":"93","author":"Bansal","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2023041905563273800_R65","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1053\/j.ajkd.2009.02.016","article-title":"Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis","volume":"54","author":"Silva","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2023041905563273800_R66","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"2023041905563273800_R67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","article-title":"The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies","volume":"167","author":"Xiao","year":"2005","journal-title":"Am J Pathol"},{"key":"2023041905563273800_R68","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2353\/ajpath.2007.060573","article-title":"Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies","volume":"170","author":"Xiao","year":"2007","journal-title":"Am J Pathol"},{"key":"2023041905563273800_R69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1681\/ASN.2008050497","article-title":"C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis","volume":"20","author":"Schreiber","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2023041905563273800_R70","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1681\/ASN.2007111166","article-title":"Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo","volume":"19","author":"Nolan","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2023041905563273800_R71","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","article-title":"Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo","volume":"106","author":"Little","year":"2005","journal-title":"Blood"},{"key":"2023041905563273800_R72","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/art.22741","article-title":"Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis","volume":"56","author":"Guilpain","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R73","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood.V94.7.2487.419k07_2487_2496","article-title":"Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules","volume":"94","author":"Witko-Sarsat","year":"1999","journal-title":"Blood"},{"key":"2023041905563273800_R74","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"2023041905563273800_R75","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","article-title":"Membrane expression of proteinase 3 is genetically determined","volume":"14","author":"Schreiber","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2023041905563273800_R76","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/ard.2006.063230","article-title":"Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls","volume":"66","author":"van Rossum","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2023041905563273800_R77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOR.0b013e3283331594","article-title":"Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener\u2019s granulomatosis","volume":"22","author":"Witko-Sarsat","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"2023041905563273800_R78","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2007-03-080457","article-title":"Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis","volume":"110","author":"Kantari","year":"2007","journal-title":"Blood"},{"key":"2023041905563273800_R79","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.4049\/jimmunol.1200600","article-title":"Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation","volume":"189","author":"Gabillet","year":"2012","journal-title":"J Immunol"},{"key":"2023041905563273800_R80","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"key":"2023041905563273800_R81","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2249.2009.04072.x","article-title":"Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis","volume":"159","author":"Primo","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2023041905563273800_R82","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/ard.2006.064626","article-title":"Rats and mice immunised with chimeric human\/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes","volume":"66","author":"van der Geld","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2023041905563273800_R83","doi-asserted-by":"crossref","first-page":"e28626","DOI":"10.1371\/journal.pone.0028626","article-title":"Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system","volume":"7","author":"Little","year":"2012","journal-title":"PLoS ONE"},{"key":"2023041905563273800_R84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-3083.1998.00348.x","article-title":"Effect of anti-neutrophil cytoplasmic antibodies on proteinase 3-induced apoptosis of human endothelial cells","volume":"48","author":"Taekema-Roelvink","year":"1998","journal-title":"Scand J Immunol"},{"key":"2023041905563273800_R85","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1681\/ASN.2005040347","article-title":"Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement","volume":"16","author":"Holmen","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2023041905563273800_R86","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/ard.2005.040980","article-title":"Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis","volume":"65","author":"Woywodt","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2023041905563273800_R87","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","article-title":"Cytokine profiles in Wegener\u2019s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation","volume":"42","author":"Csernok","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2023041905563273800_R88","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1365-2249.2001.125002332.x","article-title":"Th2 dominance in nasal mucosa in patients with Wegener\u2019s granulomatosis","volume":"125","author":"Balding","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"2023041905563273800_R89","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","article-title":"Peripheral blood and granuloma CD4(+)CD28(\u2212) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener\u2019s granulomatosis","volume":"160","author":"Komocsi","year":"2002","journal-title":"Am J Pathol"},{"key":"2023041905563273800_R90","article-title":"Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis","author":"Mahr","journal-title":"Ann Rheum Dis"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/90\/1063\/290\/50019978\/postgradmedj-90-290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/90\/1063\/290\/50019978\/postgradmedj-90-290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T06:05:30Z","timestamp":1681884330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/90\/1063\/290\/6992060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,15]]},"references-count":90,"journal-issue":{"issue":"1063","published-online":{"date-parts":[[2014,4,15]]},"published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.1136\/postgradmedj-2013-203255rep","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,5]]},"published":{"date-parts":[[2014,4,15]]}}}